Comparison of Consecutive Therapeutic Effects of Nanoemulsion and Emulsion Cyclosporin in Dry Eye Patients after Short-Term Treatment with Topical Fluorometholone

Table 1

Baseline characteristics in patients.

	Group 1 (n = 9) (nanoemulsion CsA)	Group 2 (n = 15) (emulsion CsA)	value
Age (years)	58.6 ± 11.4	62.1 ± 6.4	0.279
Sex (Male/female)	4/5	4/11	0.355
BCVA (logMAR)	0.08 ± 0.11	0.12 ± 0.11	0.262
IOP (mmHg)	9.4 ± 1.6	9.8 ± 2.4	0.643
SANDE score	73.9 ± 17.8	67.8 ± 24.1	0.344
TBUT (sec)	2.6 ± 1.1	2.3 ± 0.7	0.403
Schirmer (mm)	9.0 ± 7.6	8.9 ± 7.2	0.077
CSS (pts)	0.6 ± 1.1	0.3 ± 0.7	0.248
MGD stage (0–4)	1.8 ± 0.4	1.9 ± 0.4	0.574
MG expression (pts)	2.6 ± 1.1	2.3 ± 0.7	0.360

Values are presented as the mean ± standard deviation. Mann–Whitney test; the chi-square test. CsA: cyclosporin; BCVA: best corrected visual acuity; IOP: intraocular pressure; SANDE: symptom assessment in dry eye; TBUT: tear film breakup time; CSS: corneal staining score (NEI scale, 0–15); MGD: meibomian gland dysfunction; MG: meibomian gland.